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Abstract: Background: Faster rates of cognitive decline are likely to result in earlier onset of cognitive
impairment and dementia. D-galactose, a derivative of lactose, is used in animal studies to induce
neurodegeneration. Milk is the primary source of lactose in the human diet, and its effects on
cognitive decline have not been fully evaluated. Objective: Assess the association of milk intake
with change in cognitive function over 20 years. Methods: A total of 13,751 participants of the
Atherosclerosis Risk in Communities (ARIC) cohort completed a food frequency questionnaire and
three neurocognitive evaluations from 1990 through 2013. Two single nucleotide polymorphisms
(SNPs) were used to determine lactase persistence (LCT-13910 C/T for Whites and LCT-14010 G/C
for Blacks). Mixed-effects models were used to study the association of milk intake with cognitive
change. Multiple imputations by chained equations were used to account for attrition. Results:
Milk intake greater than 1 glass/day was associated with greater decline in the global z-score over a
20-year period. The difference in decline was 0.10 (95% CI: 0.16, 0.03) z-scores, or an additional 10%
decline, relative to the group reporting “almost never” consuming milk. Conclusions: Replication of
these results is warranted in diverse populations with greater milk intake and higher variability of
lactase persistence genotype.
Keywords: lactose; lactase persistence; oxidative stress; cognitive decline; dementia; aging
1. Introduction
Cognitive decline refers to the diminution in mental processes such as attention, short-term and
long-term memory, reasoning, coordinating of movement, and planning of tasks, which are crucial
for the conduct of daily living activities [1]. While the rate of decline in cognition varies among
individuals [2–5], the factors affecting it are poorly understood, mainly due to limited long-term data
on cognitive performance. Faster rates of decline may lead to earlier onset of cognitive impairment and
dementia, resulting in significant burden to those affected and their caregivers [6,7]. Since evidence
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from neurobiological and cognitive performance studies suggest that age-related cognitive decline
begins at midlife, the focus of research has shifted to modifiable risk factors and younger populations,
to identify behaviors that can prevent or delay the progression to cognitive impairment [8].
Animal studies indicate that oxidative stress plays an important role in neurodegeneration [9–12].
The brain is particularly vulnerable to oxidative damage due to its high metabolic activity and low
antioxidant defense [13–23]. Administration of D-galactose, a metabolic derivative of lactose, has
been used extensively to mimic cognitive aging through oxidative stress in animal models [24–29].
D-galactose reacts readily with free amines of amino acids in proteins and peptides to form advanced
glycation end products, which accumulate in the organs by binding with cell surface receptors or
cross-linking with proteins, altering their structure and function and resulting in the generation of
reactive oxygen species (ROS), increased oxidative stress, and inflammation [30–34]. Milk, the main
source of lactose in the human diet, plays important roles in the growth and development of children
due to its high fat and protein content, although its health effects in adults have not been studied as
extensively [35–37]. In particular, few studies have explored the influence of milk on health outcomes
by lactase persistent (LP) and non-persistent (LNP) genotype, which determines the pathways through
which lactose in milk is metabolized [38,39]. In lactase persistence, lactose is broken down by the
enzyme lactase in the small intestine, resulting in the formation of D-galactose—a contributor to ROS
formation. Among those who are LNP, lactose is broken down in the colon by bacteria, resulting in
the excessive formation of byproducts of bacterial fermentation, but not D-galactose. Since the two
metabolic pathways differ significantly, the effect of lactose on health could differ by genotype.
Studies looking at the association of milk intake with cognitive performance are few. Most are
cross-sectional in design, have a small number of participants, or involve only older adults who had
already experienced significant decline at the time of exposure assessment [40–48]. Thus, the aim
of this study was to assess the association of milk intake in midlife with cognitive change over a
20-year period in a large biracial cohort, and to explore potential differences in the association by
LP/LNP genotype.
2. Materials and Methods
2.1. Study Population
The Atherosclerosis Risk in Communities (ARIC) cohort is a prospective study of 15,792 adults
who were selected through probability sampling from four US communities: Washington County,
Maryland; Forsyth County, North Carolina; suburbs of Minneapolis, Minnesota; and Jackson,
Mississippi. Participants were examined at five visits, with the first four visits approximately 3 years
apart, and a fifth visit conducted 15 years following visit 4 (Figure 1). At baseline (1987–1989),
the participants were 45–64 years of age, 56% were female, and 24% were Black. At the time of the
study visits, participants received extensive examinations, including assessments of their medical
conditions and physical functions. Annual (semi-annual since 2011) telephone follow-up interviews
of ARIC cohort participants were also conducted [49]. A food frequency questionnaire (FFQ) was
administered at visits 1 (1987–1989) and visit 3 (1993–1995). Cognitive function was assessed at visits 2
(1990–1992), 4 (1996–1998), and 5 (2011–2013). Analysis included participants who completed the FFQ
on at least one occasion (visit 1) and those who completed cognitive assessments at visit 2, 4, and 5.
Excluded were participants of race other than White or Black (n = 48) and Blacks from Washington
County and Minneapolis (n = 55) due to small sample size. Also excluded were participants missing
milk intake data (n = 27), those missing one or more cognitive function tests at baseline (n = 1649),
and those with extreme reported caloric intake (<600 kcal or >4200 kcal per day for men, <500 kcal or
>3600 kcal per day for women) (n = 261).
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Figure 1. Timeline of the Atherosclerosis Risk in Communities (ARIC) study.
2.2. Assessment of Cognitive Function
Verbal learning and short-term memory were assessed via the Delayed Word Recall Test (DWRT),
in which participants were asked to learn 10 nouns, use them in sentences, and then recall those nouns
after 5 min. The score on the test is the number of words recalled (0–10) [50]. Executive function was
assessed via the Digit Symbol Substitution Test (DSST), during which participants use a key to write
symbols corresponding to numbers in 90 s. The score on the test is the number of correctly written
symbols from 0 to 93 [51]. Executive function and expressive language were assessed via the Word
Fluency Test (WFT), during which participants generate as many words starting with the letters F, A,
and S as possible within 60 s, with one trial per letter. The score on the test is the sum of all the correct
words generated [52].
All test scores were converted to z-scores standardized to the visit 2 mean and standard deviation,
calculated for each test by subtracting each participant’s test score at each visit from the visit 2 mean
and dividing by the visit 2 standard deviation. Global cognition z-scores standardized to visit 2 global
z mean and standard deviation were generated for each visit by averaging the z-scores of the 3 tests,
and then subtracting the global mean and dividing by standard deviation from the visit 2 global
z-score [53–56].
2.3. Assessment of Milk Intake
An interviewer-administered food frequency questionnaire (FFQ) was used to assess dietary
intake [57]. Total milk intake was estimated as combined intake of skim/low-fat and whole milk,
reported in 8-ounce glasses with frequency of intake ranging from “Almost never” to “>6 times per
day” in 9 categories. A number was assigned at mid-category of reported frequency (e.g., “3–5 times
per day” = 4 times per day) for each type of milk to obtain the average daily intake in glasses/day,
then added together across each milk type to obtain total milk intake, which was then reclassified into
4 categories: “Almost never”, “<1 glass/day”, “1 glass/day”, and “>1 glass/day”. Intake of all dairy
included skim/low-fat and whole milk, yogurt, ice-cream, cottage cheese, other cheese, and butter in
servings per day. One serving of dairy was equal to an 8-ounce cup of milk, 1 cup of yogurt, 1/2 cup
of ice-cream, 1/2 cup cottage cheese, 1 slice of hard cheese, or 1 pat of butter. For participants with two
FFQ assessments, an average was taken across visits for all dietary intake variables. For those with an
FFQ at baseline only, the baseline reported amount was used.
2.4. Diet Quality Score
The Healthy Food Score, adapted from Steffen et al. [58,59] was created by summing the scores of
food groups. Food groups included dairy other than milk (cottage cheese, other cheese, yogurt, ice
cream, butter), vegetables, fruit (without juice), fruit juice, legumes, refined grain, whole grain, nuts,
fish, meat (combined poultry, processed meat, beef, pork, and lamb), diet beverages, sugar-sweetened
beverages, and coffee and tea. Daily intake of food groups was categorized into quintiles, except
alcohol intake, legume, and beverages. Each quintile of food group intake was assigned a score: 0–4.
For dairy, vegetables, fruit (without juice), fruit juice, refined grain, whole grain, nuts, and fish, scores
were assigned in the following order: Quintile 1 = 0, Quintile 2 = 1, Quintile 3 = 2, Quintile 4 = 3,
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Quintile 5 = 4; for meat, the score was the reverse. Due to the limited range of intake, scoring for
intake of legumes was 0, 1, and 2, if daily intake was 0, <1, and ≥1 serving, respectively. The score
was reversed for diet beverages and sugar-sweetened beverages: 2, 1, and 0 for 0, >0 to <1, and one
or more servings usually consumed per day, respectively. Daily coffee and tea intake was scored
in five categories from 0 to 4, for 0, >0 to ≤2, >2 to ≤4, >4 to ≤6, and >6 cups per day, respectively.
For alcohol intake, a score of 4 was assigned to the men who consumed between 10 and 50 g per day
and to women who consumed between 5 and 30 g per day; otherwise a score of 0 was assigned [59].
2.5. Covariates
Analyses included the following covariates: visit 1 reported sex, race, study center, educational
attainment (<high school, high school, >high school), time spent in moderate to vigorous physical
activity in MET-minutes/week; visit 2 age, body mass index (BMI) in kg/m2, smoking status (ever
smoker vs never smoker), alcohol consumption (ever drinker vs never drinker), diet quality score
derived from the average of reported dietary intake [58,59]; visit 2 prevalent health condition such as
diabetes, hypertension, coronary heart disease (CHD), and cancer. Diabetes was defined as fasting
blood glucose level of ≥126 mg/dL, or non-fasting blood glucose level of ≥200 mg/dL, history of past
diagnosis of diabetes by a physician, or diabetes medication use in the past 2 weeks. Hypertension
was defined as diastolic blood pressure of ≥90 mm/Hg or systolic blood pressure of ≥140 measure
at visit 2, or use of hypertension medication in the past 2 weeks. Prevalent CHD was defined as
self-reported history of CHD at the baseline visit 1 or adjudicated CHD event between baseline and
visit 2. CHD events included non-fatal myocardial infarction, coronary artery bypass surgery, or
angioplasty. Prevalent cancer cases were defined as self-reported history of any cancer. Apolipoprotein
E ε4 allele number (APOEe4) was included in analyses as it is a strong predictor of cognitive decline
and risk for cognitive impairment.
2.6. Lactase Persistence Genotype
Lactase persistence, or the ability to digest lactose into glucose and galactose in adulthood,
emerged 7500–10,000 years ago among populations that domesticated milk animals and consumed
milk [60,61]. Dominant mutations occurred in the lactase promoter region upstream from the
lactase phlorizin hydrolase locus on chromosome 2q21, retaining intestinal lactase into adulthood.
The single nucleotide polymorphisms (SNPs) most frequently used to determine LP/LNP status are
rs4988235 (LCT-13910C>T) in the populations of European descent and rs145946881 (LCT-14010G>C)
in populations of African descent; however, studies in African countries suggest that there are other
SNPs also associated with lactose digestion in these populations. The imputed genotypes LCT-13910
C/T in Whites [60] and LCT-14010G/C in Blacks [62] were used to denote LP/LNP in this cohort.
Individuals with two minor alleles were classified as LNP.
Data on LP/LNP genotype were obtained for consenting ARIC participants using the Affymetrix
Genome-Wide Human SNP Array 6.0 (Affymetrix, Santa Clara, CA, USA) and the IBC Chip Array
(Affymetrix, Santa Clara, CA, USA). Genotypes were excluded for call rates <90%, MAF (minor
allele frequency) <1%, Hardy–Weinberg equilibrium deviation <10−6, and genotype frequency that
was different at p <10−6 from prior genotyped samples. Imputation was performed in two steps:
(1) pre-phasing with ShapeIt, and (2) imputation with IMPUTE2. After frequency and genotyping
pruning, there were 695,783 SNPs in the final set used for the imputation (669,450 autosomal SNPs).
Final imputations were performed using IMPUTE2 based on the 1000 Genomes Phase I integrated
variant set release (v3) in NCBI build 37 (hg19) reference panel haplotypes. All 1092 individuals
were used for the imputation from the reference panel. The final sample with genetic data used
for imputation was 9713 Whites and 2871 Blacks. Principal components were generated using the
Eigensoft package (http://genepath.med.harvard.edu/~reich/Software.htm), and ancestry outliers
were removed. The final sample with genetic data used for imputation was 9713 Whites and
2871 Blacks.
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2.7. Statistical Analysis
Baseline (visit 2) characteristics of the study population were reported by milk-intake category.
To study the association between the four levels of milk intake and cognitive change from visit 2 to
visit 5, we used mixed-effect models to account for repeated measures across study visits. A linear
spline term was applied with a knot at six years, equal to the mean duration between visits 2 and
4 [53]. We performed the analyses using 3 models: (1) demographic model, adjusted for age, gender,
and race-center; (2) full model, adjusted for age, gender, race-center, education level, APOEe4, BMI
(kg/m2), smoking, drinking, diabetes, hypertension, physical activity (MET-min/week), total energy
intake (kcal), and diet quality score; and (3) full model with food group replacing diet quality score
(food groups that were significant in the model: protein (g/day), fat (g/day), servings of fruit, servings
of vegetable, servings of sugar-sweetened beverages, and servings of non-milk dairy products for the
association with total milk and skim/low-fat milk).
Analyses were stratified by race and by LP/LNP genotype. We used interaction terms with
smoking, diabetes, diet quality score, fruit and vegetable intake, total fat intake, and physical activity
to test for effect modification. Those variables were selected because of the previously reported
association with cognitive performance or oxidative stress, the proposed mechanism through which
milk intake could affect cognition.
Attrition was addressed with multiple imputations by the chained equations (MICE) [63] method.
The missing values for global z-score were imputed based on the observed values for a given individual,
as well as the relations observed in the data for other participants. The values were imputed multiple
times, creating a more accurate estimation of a standard error. Variables used to impute global z-scores
and individual test scores for participants who did not attend visit 5, but were alive at the time,
included retrospective ascertainment of hospitalization with dementia codes, Telephone Interview for
Cognitive Status (TICS-m) questionnaire, clinical dementia rating (CDR) scale conducted with proxies,
suspect dementia status, global z-scores from visit 2 and 4, as well as APOE4, demographic and
socioeconomic (age, gender, race-center, BMI, education, income), behavioral (smoking and alcohol
consumption), and cardiovascular risk factors (CHD, diabetes, hypertension, stroke, self-reported poor
health). Interaction terms were derived empirically. Validation of the MICE approach for cognitive
data in ARIC has been previously reported and it has been determined that MICE produced unbiased
imputed values [64]. All statistical analyses were performed using Stata14.2 (StataCorp, College
Station, TX, USA).
3. Results
3.1. Total Milk Intake
The final analytic set included 13,752 participants who had milk intake data and baseline cognitive
performance data. Most participants (88%) reported milk intake on at least two occasions. The Pearson
correlation coefficient for milk intake reported on two occasions was 0.44, which is consistent with
previously reported estimates [65]. Average milk intake in this population was 0.87 glasses/day.
Skim milk accounted for 75% of total milk intake. Overall, 11% of participants reported almost never
drinking milk, 50% reported consuming <1 glass per day, 15% reported consuming 1 glass/day and
24% reported consuming >1 glass per day. A greater proportion of Black participants reported almost
never drinking milk (16.2%, compared to 9.8% among Whites). Participant characteristics by milk
intake group are presented in Table 1. Participants who reported drinking more milk were more likely
to be male, White, have more years of education, have better diet quality score with greater intake of
fruits and vegetables, have lower intake of meat and sugar-sweetened beverages (Table S1), and more
time spent in moderate to vigorous physical activity. Baseline scores for the three cognitive tests did
not differ by milk intake group (Table 1).
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Table 1. Baseline (visit 2) characteristics of study participants by milk intake group. ARIC Study,
1990–1992.
Covariates Milk Intake Group
Almost Never <1 Glass/Day 1 Glass/Day >1 Glass/Day
n = 1554 n = 6872 n = 2036 n = 3290
Age, mean (SD) 56.7 (5.6) 57.2 (5.6) 58.5 (5.7) 57.9 (5.8)
Black, % 530 (34.1%) 1833 (26.7%) 360 (17.7%) 542 (16.5%)
Female, % 1023 (65.8%) 3879 (56.4%) 1096 (53.8%) 1664 (50.6%)
Study site, %
Forsyth County, NC 328 (21.1%) 1894 (27.6%) 584 (28.7%) 760 (23.1%)
Jackson, MS 484 (31.1%) 1641 (23.9%) 320 (15.7%) 469 (14.3%)
Minneapolis, MN 335 (21.6%) 1499 (21.8%) 601 (29.5%) 1293 (39.3%)
Washington County, MD 407 (26.2%) 1838 (26.7%) 531 (26.1%) 768 (23.3%)
Education, % <High School 415 (26.8%) 1474 (21.5%) 390 (19.2%) 627 (19.1%)
Smoking, % Never 564 (36.3%) 2771 (40.3%) 839 (41.2%) 1301 (39.6%)
Drinking, % Never 366 (23.6%) 1582 (23.0%) 476 (23.4%) 654 (19.9%)
BMI (kg/m2), mean (SD) 27.9 (5.7) 28.1 (5.5) 27.7 (5.1) 27.9 (5.1)
Diabetes, % 220 (14.3%) 945 (13.8%) 311 (15.3%) 555 (16.9%)
Hypertension, % 622 (40.2%) 2451 (35.7%) 721 (35.6%) 1076 (32.8%)
Diet score, mean (SD) 19.3 (4.9) 20.7 (4.7) 22.0 (4.7) 22.1(4.8)
Lactose intake (g), mean (SD) 2.3 (3.0) 7.7 (5.5) 14.9 (3.5) 27.8 (15.4)
Physical activity (met-min/week) 500 (647) 674 (825) 822 (907) 728 (782)
APOEe4 allele, % present 565 (33.8%) 2218 (30.2%) 669 (30.7%) 1071 (30.3%)
Lactase persistence (Whites)
CC (Lactase non-persistent) 149 (17.0%) 444 (10.1%) 96 (6.5%) 139 (5.8%)
CT (Lactase persistent) 326 (37.1%) 1722 (39.2%) 589 (39.5%) 922 (38.2%)
TT (Lactase persistent) 403 (45.9%) 2224 (50.7%) 803 (54.0%) 1355 (56.1%)
Cognitive test scores
DWRT, mean (SD) 6.6 (1.5) 6.6 (1.5) 6.5 (1.5) 6.6 (1.5)
DSST, mean (SD) 42.6 (15.2) 44.6 (14.4) 45.2 (13.7) 45.6 (13.6)
WFT, mean (SD) 31.2 (12.9) 33.4 (12.4) 33.5 (12.6) 33.8 (12.3)
Abbreviations: BMI, body mass index; APOEe4, apolipoprotein epsilon 4 alleles; DWRT, delayed word recall test;
DSST, digit symbol substitution test; WFT, word fluency test.
Results of mixed model analyses suggest the presence of an association of milk intake with
cognitive decline over a 20-year period (Table 2, Figure 2). The response was graded across milk intake
categories. The difference in the 20-year change in global z-score between those who reported almost
never drinking milk and those who reported drinking >1 glass/day was −0.10 (95% CI: −0.16, −0.03)
z-scores, equivalent to a 10% additional decline. Decline in the DSST z-score (a test of processing speed)
and DWRT z-score (a test of short-term memory) contributed the most to the difference in decline.
We observed no effect modification of this association by race (Figure 3), or by other a priori
hypothesized covariates (smoking, diabetes, diet quality score, fruit and vegetable intake, total fat
intake, and physical activity).
Availability of three cognitive assessments allowed us to compare change in cognitive function
during two time periods: from visit 2 to visit 4 (6 years) and from visit 4 to visit 5 (14 years). Decline
in cognitive function occurred at a faster rate during the later time period, however the difference in
decline by milk intake group was observed during both times (Table S2).
Estimates did not change when replacing diet quality score with individual food groups in the
model (Model 2 vs. Model 3).
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Table 2. Estimated, adjusted * race-specific difference in the 20-year change in cognitive performance
by milk intake category. ARIC Study.
Test 20-Year Decline Difference Percent
Global z
Almost never −0.94 (−1.00, −0.88) ref ref
<1 glass/day −0.99 (−1.01, −0.96) −0.05 (−0.11, 0.02) 5%
1 glass/day −1.00 (−1.05, −0.95) −0.06 (−0.13, 0.02) 6%
>1 glass/day −1.04 (−1.08, −1.01) −0.10 (−0.16, −0.03) 11%
DWRT z
Almost never −1.15 (−1.23, −1.06) ref ref
<1 glass/day −1.19 (−1.23, −1.15) −0.04 (−0.13, 0.06) 3%
1 glass/day −1.18 (−1.26, −1.11) −0.03 (−0.14, 0.08) 3%
>1 glass/day −1.25 (−1.31, −1.19) −0.10 (−0.20, 0.00) 9%
DSST z
Almost never −0.78 (−0.82, −0.74) ref ref
<1 glass/day −0.82 (−0.84, −0.80) −0.04 (−0.09, 0.00) 5%
1 glass/day −0.85 (−0.89, −0.81) −0.07 (−0.12, −0.01) 9%
>1 glass/day −0.87 (−0.89, −0.84) −0.09 (−0.14, −0.03) 12%
WFT z
Almost never −0.24 (−0.29, −0.19) ref ref
<1 glass/day −0.28 (−0.30, −0.26) −0.04 (−0.09, 0.02) 16%
1 glass/day −0.26 (−0.30, −0.22) −0.02 (−0.08, 0.05) 8%
>1 glass/day −0.29 (−0.33, −0.26) −0.05 (−0.11, 0.01) 21%
Abbreviations: DWRT, delayed word recall test; DSST, digit symbol substitution test; WFT, word fluency test. Global
z is a summary score, equal to the average of the three domain-specific z-scores. * Models adjusted for age, gender,
race-center, education level, APOE4, BMI, smoking, alcohol intake, diabetes, physical activity, total energy intake,
and diet quality. In column “Percent”, positive values represent % additional decline relative to the referent group.
Figure 2. Estimated difference in the 20-year change in cognitive performance by milk intake group
relative to those who reported “almost never” consuming milk adjusted for age, gender, race-center,
education level, APOE4, BMI, smoking, alcohol intake, diabetes, physical activity, total energy intake
and diet quality score. ARIC Study. Abbreviations: DWRT, delayed word recall test; DSST, digit symbol
substitution test; WFT, word fluency test. Global z is a summary score, equal to the average of the three
domain-specific z-scores.
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Figure 3. Estimated difference in the 20-year change in global z-score stratified by race and by
LP/LNP genotype among Whites adjusted for age, gender, race-center, education level, APOE4,
BMI, smoking, alcohol intake, diabetes, physical activity, total energy intake and diet quality. ARIC
Study. Abbreviations: LNP, lactase non-persistence; LP, lactase persistence. “Almost never” used as a
referent category.
3.2. Lactase Persistence
Among Whites, 9% of participants were classified as being lactase non-persistent. The presence of
minor allele among Blacks was only 0.7%, with no participants being classified as lactase non-persistent.
Thus, stratified analysis by LP/LNP genotype was restricted to Whites. Those who were classified
as LP consumed on average more milk than those who were classified as LNP. Stratified analysis
suggested that milk consumption may have a greater effect among those classified as LNP, however a
graded response by milk intake group was not observed, possibly due to small numbers of participants
classified as LNP (Figure 3).
3.3. Skim/Low-Fat Milk and Total Dairy
The majority of participants reported drinking skim/low-fat milk, which accounted for 75% of
total milk intake. Those who reported drinking more total milk also reported consuming more other
dairy products and thus had greater all-dairy consumption overall (Table S3). Only 39 participants
reported never consuming any dairy products, thus the exposure to all dairy products was classified
into quartiles (Table S4).
The association of skim/low-fat milk and all dairy with change in cognitive function was similar
to the association observed with total milk. Those consuming more than 1 glass/day of skim/low-fat
milk and those in the 4th quartile of all dairy intake experienced a faster rate of cognitive decline over
the 20-year period. This was true for the overall population and in race-stratified analyses (Table S5).
4. Discussion
This is one of the few prospective studies to examine the association of milk intake with cognitive
performance. It is the only study of this association with multiple measures of cognitive function,
allowing the assessment of change in cognition over time.
Our results suggest that greater milk intake at midlife may be associated with greater rate of
cognitive decline over a 20-year period. These results are consistent with results from a recent study of
3076 participants 65.5 years of age at the time of neurocognitive evaluation, in which milk consumption
was associated negatively with verbal and working memory performance [48]. Three other prospective
studies reported that full-fat milk intake was associated with poor cognitive function, and that high
saturated fat intake from milk products was associated with poor cognitive function and increased
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risk of mild cognitive impairment [45,46,66], although the effect of fat from milk was emphasized,
as opposed to lactose.
We hypothesized that the effect of milk on cognitive function is through the effect of lactose on
oxidative stress. Given the proposed mechanism, we chose total milk intake as the main exposure,
since milk contains several times more lactose than any other dairy product, although associations of
skim/low-fat milk and all dairy with cognitive decline were considered as part of sensitivity analyses,
which showed similar associations.
After accounting for total fat intake in our model, the association of total milk, skim/low-fat, and
total dairy with cognitive change remained constant. Further, there was no effect modification of the
associations by tertiles of total fat intake, suggesting that the dairy fat content may not be the culprit in
the observed faster rate of cognitive decline.
The distribution of LP/LNP genotype in our population differed from the previously reported
estimate in the US [67]. Only 9% of Whites where classified as LNP (as compared to previously reported
20%), and the SNP for LP/LNP among Blacks available in our study showed almost no variation.
Considering that the estimated prevalence of LNP among Blacks in the US has been estimated at
80%, we concluded that the imputed SNP available in ARIC most likely did not characterize lactase
persistence among Blacks [67,68].
The effect of milk intake on cognitive decline was greater among those participants classified as
LNP. In the milk intake group with most participants of LNP genotype (<1 glass/day), we observed a
significantly faster rate of decline over the 20-year period, compared to LNP participants who reported
“almost never” drinking milk. However, due to the small number of participants characterized as LNP,
we lacked power to capture the graded response that was observed in the overall analysis. Overall,
findings from the LP/LNP stratified analysis did not support our hypothesis of milk intake having
an effect on cognitive decline through the mechanism of D-galactose, which would have resulted in a
greater decline among LP population.
Our study had several limitations, including attrition, which is a concern for all longitudinal
studies with long follow-up. Although attrition was addressed through MICE, taking into account
a wide range of attributes influencing attrition, it is possible that we were not able to fully account
for the effect of selective drop-out. Sensitivity analyses in which estimates of the rates of cognitive
decline were adjusted for attrition and competing risk of death through inverse probability of attrition
weighting yielded similar effect estimates (results not shown). Another limitation is the assumption
that the assessment of average milk intake at visit 1 and visit 3 reflected long-term habitual intake
throughout adulthood, which would have preceded the significant cognitive decline. Since diets
change over the life course, exposure may have been misclassified for some individuals. Despite such
limitations, the FFQ has been determined as a reliable method of assessing long-term intake and it is
likely that the ranking of individuals with respect to milk intake was accurate [69]. In addition, we had
two assessments of milk intake for most participants, thus we were able to reduce reporting error by
taking the average across visits.
Strengths of our study include a population-based biracial cohort of large size and with extensive
follow-up, repeat assessments of the exposure and outcome, and data on three cognitive tests that
permit a study of the association of milk intake with three cognitive domains. Assessment of exposure
prior to the assessment of outcome reduced the likelihood for reverse causation, as poor cognitive
health may affect dietary choices and ability to follow dietary recommendations and accurately report
diet. Multiple assessments of cognitive function allowed capturing change in cognitive performance
over time, which reduced confounding that is common to studies using one point in time assessment
of cognitive performance [54].
5. Conclusions
Results of our study suggest that milk intake at midlife may be associated with a greater rate
of cognitive decline from midlife to late-life. Further longitudinal studies in multiethnic groups,
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including those with higher prevalence of lactase non-persistence, are needed to better understand
the link between milk intake and change in cognitive performance among adults. Other potential
mechanisms through which milk intake may affect the rate cognitive decline should be explored.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6643/9/10/1134/s1,
Table S1: Energy adjusted diet composition of study participants by milk intake group, mean (SE). ARIC Study,
Table S2: Change in global z score by follow-up time period. ARIC Study, Table S3: Mean intake of milk and
other dairy products by milk intake group. ARIC Study, Table S4: Distribution of milk intake groups and other
dairy intake by total dairy intake quartiles. ARIC Study. Table S5. Estimated, adjusted * difference in the 20-year
cognitive change by type of dairy intake. ARIC Study.
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